Lyons-Williams Lori
SEC insider (Form 3/4/5 filer). CIK 0001693564. Director at Contineum Therapeutics, Inc. (CTNM) and 1 other issuer. 10 reported Form 4/5 transactions since Sep 2024; latest on Jun 26, 2026. Located in SAN DIEGO, CA.
Companies Lyons-Williams Lori has filed insider reports for
- Contineum Therapeutics, Inc. (CTNM): Director
- RAPT Therapeutics, Inc. (RAPT): Director
Lyons-Williams Lori
CIK: 0001693564
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Jun 26, 2026CTNM
Contineum Therapeutics, Inc.
AwardDirectStock Option (right to buy)
19K shares- - Mar 3, 2026RAPT
RAPT Therapeutics, Inc.
Tender OfferDirect5K shares- - Mar 3, 2026RAPT
RAPT Therapeutics, Inc.
DispositionDirectDirector Stock Option (right to buy)
1.1K shares- - Mar 3, 2026RAPT
RAPT Therapeutics, Inc.
DispositionDirectDirector Stock Option (right to buy)
1.6K shares- - Mar 3, 2026RAPT
RAPT Therapeutics, Inc.
DispositionDirectDirector Stock Option (right to buy)
4.6K shares- - Mar 3, 2026RAPT
RAPT Therapeutics, Inc.
DispositionDirectDirector Stock Option (right to buy)
32.2K shares- - Mar 3, 2026RAPT
RAPT Therapeutics, Inc.
DispositionDirectDirector Stock Option (right to buy)
2.8K shares- - Jan 30, 2026RAPT
RAPT Therapeutics, Inc.
AwardDirect5K shares- - Jun 26, 2025CTNM
Contineum Therapeutics, Inc.
AwardDirectStock Option (right to buy)
14.8K shares- - May 29, 2025RAPT
RAPT Therapeutics, Inc.
AwardDirectDirector Stock Option (right to buy)
257.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 26, 2026 |  CTNM Contineum Therapeutics, Inc. | Award Stock Option (right to buy) | 19,000 | - | - | Direct |
| Mar 3, 2026 |  RAPT RAPT Therapeutics, Inc. | Tender Offer | 4,956 | - | $0 | Direct |
| Mar 3, 2026 | RAPT RAPT Therapeutics, Inc. | Disposition Director Stock Option (right to buy) | 1,063 | - | - | Direct |
| Mar 3, 2026 | RAPT RAPT Therapeutics, Inc. | Disposition Director Stock Option (right to buy) | 1,618 | - | - | Direct |
| Mar 3, 2026 | RAPT RAPT Therapeutics, Inc. | Disposition Director Stock Option (right to buy) | 4,561 | - | - | Direct |
| Mar 3, 2026 | RAPT RAPT Therapeutics, Inc. | Disposition Director Stock Option (right to buy) | 32,229 | - | - | Direct |
| Mar 3, 2026 | RAPT RAPT Therapeutics, Inc. | Disposition Director Stock Option (right to buy) | 2,813 | - | - | Direct |
| Jan 30, 2026 | RAPT RAPT Therapeutics, Inc. | Award | 4,956 | - | $0 | Direct |
| Jun 26, 2025 | CTNM Contineum Therapeutics, Inc. | Award Stock Option (right to buy) | 14,750 | - | - | Direct |
| May 29, 2025 | RAPT RAPT Therapeutics, Inc. | Award Director Stock Option (right to buy) | 257,832 | - | - | Direct |
1-10 of 10 transactions